Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
535,932
-
Share change
-
-1,612
-
Total reported value
-
$5,638,113
-
Price per share
-
$10.52
-
Number of holders
-
26
-
Value change
-
+$78,914
-
Number of buys
-
14
-
Number of sells
-
7
Institutional Holders of Greenwich LifeSciences, Inc. - COM (GLSI) as of Q4 2023
As of 31 Dec 2023,
Greenwich LifeSciences, Inc. - COM (GLSI) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
535,932 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., AMERIPRISE FINANCIAL INC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, 683 Capital Management, LLC, Qube Research & Technologies Ltd, JANE STREET GROUP, LLC, and STATE STREET CORP.
This page lists
26
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.